These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 26951843)

  • 1. Conditional Deletion of Hsd11b2 in the Brain Causes Salt Appetite and Hypertension.
    Evans LC; Ivy JR; Wyrwoll C; McNairn JA; Menzies RI; Christensen TH; Al-Dujaili EA; Kenyon CJ; Mullins JJ; Seckl JR; Holmes MC; Bailey MA
    Circulation; 2016 Apr; 133(14):1360-70. PubMed ID: 26951843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 11β-Hydroxysteroid Dehydrogenase-2 and Salt-Sensitive Hypertension.
    Luft FC
    Circulation; 2016 Apr; 133(14):1335-7. PubMed ID: 26951844
    [No Abstract]   [Full Text] [Related]  

  • 3. Hsd11b2 haploinsufficiency in mice causes salt sensitivity of blood pressure.
    Bailey MA; Craigie E; Livingstone DEW; Kotelevtsev YV; Al-Dujaili EAS; Kenyon CJ; Mullins JJ
    Hypertension; 2011 Mar; 57(3):515-520. PubMed ID: 21282561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal Dysfunction Induced by Kidney-Specific Gene Deletion of
    Ueda K; Nishimoto M; Hirohama D; Ayuzawa N; Kawarazaki W; Watanabe A; Shimosawa T; Loffing J; Zhang MZ; Marumo T; Fujita T
    Hypertension; 2017 Jul; 70(1):111-118. PubMed ID: 28559392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal overexposure to glucocorticoids programs renal 11β-hydroxysteroid dehydrogenase type 2 expression and salt-sensitive hypertension in the rat.
    Tang JI; Kenyon CJ; Seckl JR; Nyirenda MJ
    J Hypertens; 2011 Feb; 29(2):282-9. PubMed ID: 21045727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure to downregulate the epithelial sodium channel causes salt sensitivity in Hsd11b2 heterozygote mice.
    Craigie E; Evans LC; Mullins JJ; Bailey MA
    Hypertension; 2012 Sep; 60(3):684-90. PubMed ID: 22777941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of 11β-hydroxysteroid dehydrogenase type 2 in human hypertension.
    Ferrari P
    Biochim Biophys Acta; 2010 Dec; 1802(12):1178-87. PubMed ID: 19909806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico structure-function analysis of pathological variation in the HSD11B2 gene sequence.
    Manning JR; Bailey MA; Soares DC; Dunbar DR; Mullins JJ
    Physiol Genomics; 2010 Aug; 42(3):319-30. PubMed ID: 20571110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal neonatal sodium handling in skin precedes hypertension in the SAME rat.
    Mullins L; Ivy J; Ward M; Tenstad O; Wiig H; Kitada K; Manning J; Rakova N; Muller D; Mullins J
    Pflugers Arch; 2021 Jun; 473(6):897-910. PubMed ID: 34028587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldosterone-sensitive HSD2 neurons in mice.
    Gasparini S; Resch JM; Narayan SV; Peltekian L; Iverson GN; Karthik S; Geerling JC
    Brain Struct Funct; 2019 Jan; 224(1):387-417. PubMed ID: 30343334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of brain mineralocorticoid receptor blockade on blood pressure and renal functions in DOCA-salt hypertension.
    Rahmouni K; Sibug RM; De Kloet ER; Barthelmebs M; Grima M; Imbs JL; De Jong W
    Eur J Pharmacol; 2002 Feb; 436(3):207-16. PubMed ID: 11858800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired 11β-Hydroxysteroid Dehydrogenase Type 2 in Glucocorticoid-Resistant Patients.
    Vitellius G; Delemer B; Caron P; Chabre O; Bouligand J; Pussard E; Trabado S; Lombes M
    J Clin Endocrinol Metab; 2019 Nov; 104(11):5205-5216. PubMed ID: 31225872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A urine-concentrating defect in 11β-hydroxysteroid dehydrogenase type 2 null mice.
    Evans LC; Livingstone DE; Kenyon CJ; Jansen MA; Dear JW; Mullins JJ; Bailey MA
    Am J Physiol Renal Physiol; 2012 Aug; 303(4):F494-502. PubMed ID: 22622456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A switch in the mechanism of hypertension in the syndrome of apparent mineralocorticoid excess.
    Bailey MA; Paterson JM; Hadoke PW; Wrobel N; Bellamy CO; Brownstein DG; Seckl JR; Mullins JJ
    J Am Soc Nephrol; 2008 Jan; 19(1):47-58. PubMed ID: 18032795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoid-mediated mineralocorticoid receptor activation and hypertension.
    Frey FJ; Odermatt A; Frey BM
    Curr Opin Nephrol Hypertens; 2004 Jul; 13(4):451-8. PubMed ID: 15199296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the 11beta-hydroxysteroid dehydrogenase type 2 in blood pressure regulation.
    Ferrari P; Krozowski Z
    Kidney Int; 2000 Apr; 57(4):1374-81. PubMed ID: 10760070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apparent mineralocorticoid excess: report of six new cases and extensive personal experience.
    Morineau G; Sulmont V; Salomon R; Fiquet-Kempf B; Jeunemaître X; Nicod J; Ferrari P
    J Am Soc Nephrol; 2006 Nov; 17(11):3176-84. PubMed ID: 17035606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the 11beta-hydroxysteroid dehydrogenase type 2 in human hypertension.
    Ferrari P; Lovati E; Frey FJ
    J Hypertens; 2000 Mar; 18(3):241-8. PubMed ID: 10726708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two Mineralocorticoid Receptor-Mediated Mechanisms of Pendrin Activation in Distal Nephrons.
    Ayuzawa N; Nishimoto M; Ueda K; Hirohama D; Kawarazaki W; Shimosawa T; Marumo T; Fujita T
    J Am Soc Nephrol; 2020 Apr; 31(4):748-764. PubMed ID: 32034107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apparent mineralocorticoid excess caused by novel compound heterozygous mutations in HSD11B2 and characterized by early-onset hypertension and hypokalemia.
    Fan P; Lu YT; Yang KQ; Zhang D; Liu XY; Tian T; Luo F; Wang LP; Ma WJ; Liu YX; Zhang HM; Song L; Cai J; Lou Y; Zhou XL
    Endocrine; 2020 Dec; 70(3):607-615. PubMed ID: 32816205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.